ASDI Deploys ACD/1D NMR Assistant to Synthetic Chemists Based on Previous Success with Automated Structure Verification Software

Toronto, Canada (May 27, 2008) —ASDI, Inc., a leader in providing materials management services for the pharmaceutical and biotechnology industries, recently implemented a suite of NMR software tools from ACD/Labs for use by their Synthetic Chemistry Team. The new software is expected to dramatically increase the efficiency and cost-effectiveness of the group.

ASDI already employs a high-throughput structure verification routine in their analytical laboratory, analyzing over 1000 samples by NMR each week. The scheme uses Advanced Chemistry Development, Inc.’s, (ACD/Labs’) ACD/1D NMR Manager and ACD/HNMR Predictor to automatically evaluate the structure-to-spectrum match of 60–80% of those samples, making the high-volume analysis and interpretation possible. The Synthetic Chemistry Team at ASDI determined that a similar tool would be useful in helping that group maximize its efficiency. However their needs were different than that of a high-throughput environment, and some of the software’s expert functionality was not needed. A better fit was found in ACD/1D NMR Assistant.

ACD/1D NMR Assistant was developed as a tool especially for chemists, and is tailored more closely to their workflow. It allows chemists to leave the instrument room and perform quick processing and reporting of NMR data from anywhere. The software’s true power lies in the ability to help evaluate the match between spectrum and structure, highlighting inconsistencies and focusing the chemist’s attention on the problematic areas.

“As part of ASDI’s Pharmaceutical Research Services Division, the Analytical Services department has been specifically designed to support manifold disciplines within the scientific community with its main focus on enabling drug discovery,” states Dr. Anthony Macherone, Associate Research Fellow at ASDI. “In support of these efforts we have implemented ACD/1D NMR Assistant software at the desktops of each chemist within the core synthetic team. In my opinion ACD/1D NMR Assistant will fit the synthetic team’s paradigm and improve their overall efficiency by providing a streamlined tool to process and verify their data, maintain their notebooks and generate reports in a unified template.”

ACD/1D NMR Assistant provides chemists with a reliable, easy-to-use software solution for quick viewing, processing, and reporting of spectra. Multiplet reports formatted for patents and publications can be produced with the click of a button.

About ASDI
Established in 1988, ASDI is a premier provider of research enabling technologies and products. ASDI’s mission is to enable chemists, biologists and management to perform their roles more efficiently. ASDI’s Pharmaceutical Research Services (PRS) division is focused on delivering high quality data and products to customers in the pharmaceutical, biotechnology, academic and NGO sectors with custom chemistry, analytical chemistry, bioanalytical and ADME/Tox services. ASDI has considerable synthetic chemistry expertise in providing intermediate scale custom synthesis, hit-to-lead and lead generation libraries and extensive analytical and bioanalytical capacity to support Discovery. Coupled with expert materials management and liquid handling, the services ASDI offers rapidly accelerate the research process.

About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs’ solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1994, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 145 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products is available at www.acdlabs.com.